Cold-Pressed Peanut Oil (Arachis hypogaea)

Cold-pressed peanut oil (Arachis hypogaea) is rich in oleic acid, linoleic acid, and polyphenolic compounds including resveratrol and p-coumaric acid, which drive its antioxidant and anti-inflammatory activity. It exerts biological effects primarily through free radical scavenging, inhibition of protein denaturation, and modulation of cancer cell proliferation pathways in preliminary laboratory models.

Origin & History

Cold-pressed peanut oil is derived from the seeds of Arachis hypogaea (peanut plant), a legume native to South America but now widely cultivated in regions like China. It is extracted mechanically without heat or chemicals, preserving natural compounds including tocopherols (292-547 mg/kg), phenols, and fatty acids, unlike refined extraction methods.

Historical & Cultural Context

No historical or traditional medicine uses for cold-pressed peanut oil were documented in the available research sources. Current evidence focuses solely on modern analytical and in vitro studies.

Health Benefits

• May inhibit colon cancer cell growth (IC50 15.09 µg/mL in HCT-116 cells) - Evidence: Preliminary (in vitro only)
• Demonstrates antioxidant activity through DPPH scavenging (IC50 23.37 µg/mL) - Evidence: Preliminary (in vitro only)
• Shows anti-inflammatory effects via protein denaturation inhibition (IC50 15.38 µg/mL) - Evidence: Preliminary (in vitro only)
• Contains higher phenolic content (up to 2.36 mg GAE/g) when cold-pressed vs solvent extraction - Evidence: Preliminary (analytical studies)
• Provides natural tocopherols and β-carotene (7.53-13.58 µg/100g) - Evidence: Preliminary (compositional analysis only)

How It Works

Cold-pressed peanut oil scavenges free radicals via its polyphenolic constituents—particularly resveratrol and p-coumaric acid—yielding an in vitro DPPH IC50 of 23.37 µg/mL, indicating moderate radical neutralization capacity. Its anti-inflammatory action involves inhibition of heat-induced albumin denaturation, a proxy for COX-pathway stabilization and prostaglandin modulation. Anticancer activity in HCT-116 colon cancer cells (IC50 15.09 µg/mL) is attributed to disruption of cell cycle progression, likely through downregulation of proliferative signaling such as the PI3K/Akt pathway, though precise receptor-level mechanisms remain uncharacterized in vivo.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on cold-pressed peanut oil were identified. Evidence is limited to one in vitro study (PMC12078917) showing anti-tumor activity against HCT-116 colon cancer cells, and one randomized double-blind crossover challenge (n=60, PMID 9133891) examining allergenic potential, finding crude peanut oil triggered reactions in 10% of peanut-allergic subjects.

Clinical Summary

Current evidence for cold-pressed peanut oil is limited entirely to in vitro studies; no human clinical trials or animal intervention studies have been published specifically on this oil's cold-pressed fraction. Laboratory data demonstrate colon cancer cell (HCT-116) growth inhibition at an IC50 of 15.09 µg/mL and DPPH radical scavenging at an IC50 of 23.37 µg/mL, both considered preliminary findings that cannot be extrapolated to therapeutic human doses. Broader research on peanut oil constituents (oleic acid, resveratrol) in humans suggests cardiovascular and anti-inflammatory benefits, but these studies used different formulations and delivery matrices. Overall, the evidence base is at the lowest tier of scientific confidence, and clinical recommendations await controlled human trials.

Nutritional Profile

Cold-pressed peanut oil is composed predominantly of fat (~99.9g per 100g), with negligible protein and carbohydrate content. Fatty acid profile: monounsaturated fats (MUFA) ~46-50g/100g, primarily oleic acid (C18:1, omega-9) at 36-67% of total fatty acids; polyunsaturated fats (PUFA) ~29-33g/100g, primarily linoleic acid (C18:2, omega-6) at 14-43%; saturated fats ~17-20g/100g, mainly palmitic acid (C16:0) at 8-14% and stearic acid (C18:0) at 1-4%. Minor fatty acids include arachidic acid (C20:0, ~1-2%), behenic acid (C22:0, ~2-3%), and lignoceric acid (C24:0, ~1%). Bioactive compounds: Vitamin E (tocopherols) ~15-21mg/100g, predominantly alpha-tocopherol (~10-13mg/100g) with minor gamma- and delta-tocopherol fractions; cold-pressing preserves significantly higher tocopherol content versus refined oil. Phytosterols ~200-220mg/100g, including beta-sitosterol (~114mg/100g), campesterol (~30mg/100g), and stigmasterol (~24mg/100g). Polyphenols: cold-pressed oil retains measurable phenolic compounds (~50-120mg GAE/kg oil), including resveratrol (0.02-0.19mg/100g), a notable differentiator from refined oils; also contains p-coumaric acid and luteolin in trace quantities. Squalene: ~30-50mg/100g. Phospholipids: trace amounts (~0.1-0.5mg/100g), higher than refined variants. Bioavailability notes: Fat-soluble vitamins (A, D, E, K) absorption is facilitated by the lipid matrix; tocopherol bioavailability is enhanced due to absence of high-heat processing; resveratrol bioavailability from oil matrix is low but measurable; phytosterols compete with dietary cholesterol for intestinal absorption, contributing modest LDL-lowering potential at dietary doses. Cold-pressing preserves heat-labile phenolics lost during refining, bleaching, and deodorization, making this a nutritionally superior form versus commercially refined peanut oil.

Preparation & Dosage

No clinically studied dosage ranges for cold-pressed peanut oil in humans have been established. In vitro studies used concentrations of 7.31-15.09 µg/mL for anti-tumor and anti-inflammatory effects. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, selenium, omega-3 fatty acids, green tea extract, turmeric

Safety & Interactions

Cold-pressed peanut oil is contraindicated in individuals with peanut allergies (Arachis hypogaea), as residual Ara h proteins—particularly Ara h 1, Ara h 2, and Ara h 3—may persist even after cold-pressing and trigger IgE-mediated anaphylaxis. It may potentiate the effects of anticoagulant medications such as warfarin due to its vitamin E content, warranting caution in patients on blood thinners. High intake of linoleic acid-rich oils like peanut oil may theoretically shift the omega-6 to omega-3 ratio unfavorably, promoting low-grade inflammation when not balanced with omega-3 sources. Pregnancy safety data are absent for supplemental doses; culinary use in non-allergic individuals is generally regarded as safe based on long-standing dietary history.